Update: S&P 500 futures have turned south on Wednesday amid doubts that outgoing President Donald Trump gives his nod to the deal as he would like to add curbs on tech companies to it. The safe-haven dollar is gaining ground. On the other hand, markets are cheering the UK's covid vaccine approval –a first in the Western world.
Get ready for Wednesday's trading:
- Point and figure target for a small distribution range — S&P 500 day trading [Video]
- ADP Nonfarm Preview: Even a minimal beat could trigger a greenback comeback
US Treasury Sec. Mnuchin: Small businesses cannot wait two or three months for more aid
US Treasury Secretary Mnuchin is testifying before the US Senate Committee on Banking, Housing, and Urban Affairs.
Key quotes
"Despite the progress on vaccines, small businesses cannot wait two or three months for more aid."
"Urging Congress to make changes to Paycheck Protection Program to simplify it, allocate unused funds."
"No reason to dispute the US Bureau of Labor Statistics' unemployment data."
"Looking forward to reviewing $908 billion bipartisan Senate COVIDaid proposal."
"More fiscal response is needed but it's important to agree on something that can be passed quickly."
Market reaction
These remarks don't seem to be having a significant impact on market sentiment. As of writing, the S&P 500 Index was up 1.33% on the day at 3,670.
More:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
GBP/USD extends recovery above 1.2500, awaits US GDP data
GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter.
Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP
Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.